University of Patras
Διερεύνηση του φαινομένου του μικροχιμαιρισμού σε πολυμεταγγιζόμενους ασθενείς
Abstract
dc:descriptionTransfusion-associated microchimerism implies the presence of allogeneic hematopoietic cells in an individual, following the transfusion of a blood product. It is a transfusion-related adverse effect/long-term consequence, which has not been well-investigated among regularly transfused patients with thalassemia.We investigated 64 regularly transfused, homozygous beta-thalassemic patients and 21 never-transfused healthy volunteer blood donors (controls) for the presence of microchimeric material in their sera, using real-time PCR targeting circulating allogeneic, both, Human Leukocyte Antigen-DR isotype (HLA-DR) and non-HLA alleles. This type of investigation was longitudinally repeated in specific patient subsets for more than 2 years. Results were correlated with clinical and laboratory parameters, peripheral blood lymphocyte immunophenotype, blood storage time, and donor’s gender to identify potential contributing factors for microchimerism generation.Overall, microchimerism was detected in 52 of the 64 patients (81.2%) and in 6 of the 21 controls (28.5%, p = 0.0001). Forty-four patients (68.7%) exhibited long-term microchimerism (persisted for more than 6 months), confirmed at all time-points investigated. Microchimerism was more frequently detected among elderly, women, splenectomized and more heavily transfused patients, and among those, who exhibited higher serum ferritin levels. In these patients, a distinct descending pattern of CD16dim+CD56dim+natural killer (NK)-cells (p < 0.001) and an ascending pattern of CD4+CD25brightCD127–regulatory T-cells (p = 0.022) for increasing allelic burden were noticed, suggesting the establishment of recipient immune tolerance against the donor-derived chimeric alleles.Both, splenectomized and non-splenectomized thalassemic patients exhibited the same trend. The storage time of transfused blood products and donor/gender mismatch had no impact on the development of microchimerism.Transfusion-associated microchimerism appears to be a very common complication among multi-transfused thalassemic patients. The potential clinical consequences of this phenomenon remain as yet unclear. Immune tolerance attributed to the underlying disease itself, and to the repeated transfusions might at least in part explain its appearance.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Matsangos, Spyridon
- Ματσάγγος, Σπυρίδων
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51658